Abstract. Bile duct-ligated rats have been widely used as a model of cholestatic liver fibrosis. The aim of this study was to analyze the sequential expression of extracellular matrix (ECM) metabolism-related genes in these rats. We analyzed the intrahepatic messenger RNA (mRNA) expression of several ECM metabolism-related genes:
Introduction
Hepatic fibrosis is the disorganized over-accumulation of extracellular matrix (ECM) components in the liver. In a normal liver, these components are constantly remodeled by matrix-degrading enzymes, leading to a controlled deposition of matrix components. Increased production of ECM components is responsible for the altered ECM metabolism of the fibrotic liver (1) . Transforming growth factor ß1 (TGF-ß1) has a prominent role in the pathogenesis of liver fibrosis and is the most important cytokine involved in the activation of hepatic stellate cells (HSCs). Acting via both paracrine and autocrine pathways, TGF-ß1 promotes ECM production and inhibits production of the matrix metalloproteinases (MMPs) for effective ECM deposition in the liver (2) . On the other hand, MMPs have degrading activity against ECM components and could potentially initiate the remodeling of the fibrotic liver. The activities of MMPs are regulated by means of the action of a family of inhibitory proteins, known as tissue inhibitors of metalloproteinases (TIMPs). In order to inhibit MMP activity, TIMPs interact with MMPs with a 1:1 stoichiometry (3, 4) . Deregulation of the enzymatic machinery involved in ECM degradation may also be an important contributing factor in the pathogenesis of hepatic fibrosis and cirrhosis.
Many animal models are used to investigate hepatic fibrosis. The common bile duct-ligated rat has been widely used as a model of human cholestatic hepatic fibrosis, including primary biliary cirrhosis and primary sclerosing cholangitis. We previously reported the preventive and therapeutic effects of antifibrotic agents using this model (5, 6) , for which it is important to know the precise sequential dynamics of ECM metabolism. However, there are few reports analyzing ECM metabolism-related gene expression in a bile duct ligation (BDL) model in detail (7) (8) (9) (10) .
The aim of the present study was to assess the gene expression levels of ECM metabolism-related genes such as TGF-ß1, connective tissue growth factor (CTGF), procollagen-·1 (collagen-I), MMP-2, MMP-13 and TIMP-1 at serial time points following BDL in rats.
Materials and methods
Animals. Wistar male rats were obtained from Japan SLC (Shizuoka, Japan) and maintained in a room at a controlled temperature of 24±2˚C with a 12-h light-dark cycle. Animals were given a standard pellet chow and water ad libitum. Establishment of the bile duct ligation model. Wistar male rats weighing approximately 250 g were used. BDL was carried out as previously described (11) . The common bile duct was double-ligated and cut between the ligatures. On days 10 (n=9), 21 (n=6) and 42 (n=5), the rats were sacrificed under pentobarbital anesthesia. On day 21, 5 untreated rats were also sacrificed as normal controls. Blood was collected from the vena cava inferior. Serum samples were frozen and stored at -80˚C. The liver was washed with saline and weighed. Liver specimens were snap frozen and stored at -80˚C, or fixed in 10% buffered formalin and embedded in paraffin for histological analysis.
Histological analysis. Sections (4-μm) of formalin-fixed, paraffin-embedded livers were processed according to routine hematoxylin and eosin and Azan-Mallory staining.
Measurement of hepatic hydroxyproline content.
Hepatic tissue (200 mg wet weight) was hydrolyzed in 4 ml of 6 N HCl at 105˚C overnight. The hydrolysate was evaporated under vacuum four times. The sediment was redissolved in distilled water, mixed with activated charcoal for decolorization, and then filtered. The solution was kept in the acidic range by adjustment to pH 5.0 and evaporated under vacuum, and the sediment was redissolved in distilled water, supplemented with 2 ml of isopropanol and incubated with 1 ml of 7% chloramine-T solution for 5 min at room temperature. Ehrlich's solution (2 ml) consisting of 1.76 g of p-dimethylaminobenzaldehyde dissolved in 4.08 ml of 60% perchloric acid and 95.5 ml of isopropanol was added, and the mixture was incubated at 60˚C for 10 min. After cooling, absorbance was measured at 562 nm. Hydroxyproline (Hyp) levels were expressed as micrograms of Hyp per gram of liver (12) . Primer (Promega) and 1 μl of 40 U/μl ribonuclease inhibitor (Wako Pure Chemical Industries Ltd., Osaka, Japan). Samples were incubated at 37˚C for 60 min, then at 95˚C for 5 min, and were subsequently cooled to 4˚C for 5 min.
Measurement of hepatic TGF

Real-time polymerase chain reaction (PCR).
Quantitative realtime PCR was performed in a final volume of 10 μl containing PCR grade water 4.1 μl, Universal ProbeLibrary probe 1 μl (Roche, Tokyo, Japan), forward primer (10 μM) 0.2 μl, reverse primer (10 μM) 0.2 μl, Light Cycler TaqMan Master 2 μl (Roche) and cDNA sample 2.5 μl of the RT samples.
The mRNA levels of TGF-ß1, CTGF, collagen-I, MMP-2, MMP-13 and TIMP-1 were assessed by real-time PCR assay using ß-actin as a housekeeping gene. The forward and reverse primer sequences used are shown in Table I . Thermal cycler conditions were as follows: hold at 95˚C for 10 min, repeat 45 cycles of 95˚C for 30 sec and 60˚C for 1 min.
DNA microarray analysis. After total RNA was extracted from liver tissue, it was reverse transcripted to cDNA using oligo(dT)24 primer with a T7 promoter sequence (Affymetrix, Santa Clara, CA, USA) and reverse transcriptase (Invitrogen). Subsequently, double-stranded cDNA was obtained using DNA polymerase (Invitrogen) and DNA ligase (Invitrogen). Biotin-labeled cDNA was obtained using T7 RNA polymerase (Enzo Life Sciences, Farmingdale, NY, USA). The cDNA of each serial group was mixed with the respective samples of the same group. This cDNA was hybridized using the GeneChip Rat Expression Array 230A (Affymetrix) for 16 h. Biotin-labeled portions were stained with fluorescent dye and evaluated using a GeneChip system for scanning the microarray. Data were analyzed using Microarray Suite software (Affymetrix) and Microsoft Excel.
Statistical analysis. The Mann-Whitney test was used to assess the statistical significance between groups. The Kruskal-Wallis test was used to assess the statistical significance between groups on different days. All statistical tests were carried out using Stat View for Windows (SAS Institute, Cary, NC, USA). P<0.05 was considered significant.
Results
Biochemical analysis and liver fibrosis.
Biochemical liver test results increased gradually in conjunction with time following BDL (Table II) . Hepatic Hyp content was significantly increased on days 21 (P<0.05) and 42 (P<0.01) in bile ductligated rats versus control rats (Fig. 1 ). Values were as follows: control rats, 2.05±0.04 μg/g wet liver; bile duct-ligated rats on day 10, 1.69±0.9 μg/g wet liver; on day 21, 9.65±4.87 μg/g wet liver; on day 42, 25.5±12.5 μg/g wet liver. Histological liver findings stained with Azan-Mallory exhibited fibrosis and bile duct proliferation 10 days after BDL, and cirrhotic liver 42 days after BDL ( Fig. 2A-D) .
Collagen-I, TGF-ß1 and CTGF expression.
Collagen-I mRNA levels in bile duct-ligated rats were significantly increased on days 10, 21 and 42 compared to the control (P<0.01; Fig. 3A ). TGF-ß1 mRNA expression levels were increased in bile ductligated rats compared to the control from day 10. This increase was sustained until day 42, but the differences were not statistically significant (P=0.63, Kruskal-Wallis test; Fig. 3B ). Following the increase in TGF-ß1 gene expression, protein levels of TGF-ß1 were significantly increased in bile duct-ligated rats on days 10, 21 and 42 versus the control (P<0.01), and also on day 10 as compared to days 21 and 42 (P<0.01). A less significant difference was observed between levels on days 21 and 42 (P=0.045) (Fig. 3C ). Values were as follows: control rats, 1.04±0.7 ng/g wet liver; bile ductligated rats on day 10, 8.15±5.27 ng/g wet liver; on day 21, 38.3±22.1 ng/g wet liver; on day 42, 67.5±37.5 ng/g wet liver.
Levels of CTGF mRNA were significantly increased in bile duct-ligated rats on day 21 (P=0.029). These increases were sustained until day 42 (P=0.009) compared to the control (Fig. 3D) .
MMP-13, MMP-2 and TIMP-1 expression.
Levels of MMP-13 mRNA significantly increased from day 10 in bile duct-ligated Table II . Biochemical data. - 
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TGFß-1, transforming growth factor ß1; CTGF, connective tissue growth factor; TIMP-1, tissue inhibitor of metalloproteinases-1; MMP, matrix metalloproteinase. rats compared to the control (P=0.004). These increases were sustained on day 21 and day 42 compared to the control (P<0.05; Fig. 4A ). Levels of MMP-2 mRNA did not change until day 21, but had the tendency to be decreased on day 42 compared to day 21 (P=0.068; Fig. 4B ). TIMP-1 mRNA levels significantly increased in bile duct-ligated rats from day 21 (P=0.006) compared to the control, and were sustained until day 42 (Fig. 4C) .
-----------------------------------------------------------------------------------------------------
DNA microarray analysis on day 10 after bile duct ligation.
DNA microarray analysis revealed that 11 genes, including calgranulin B, solute carrier family 34, thymosin and tubulin, were significantly increased (>30-fold) in bile duct-ligated rats on day 10 compared to the control (Table III) . None of the genes related to collagen production and degradation increased >30-fold after BDL.
Discussion
In this study, we examined ECM metabolism-related gene expression over 42 days following BDL in rats. Previous reports assessed findings within 30 days of BDL in rats (7) (8) (9) (10) . Histological findings and Hyp contents in this study revaled that fibrosis progressed periodically over time after BDL (days 10, 21 and 42). On day 42, the specimens exhibited liver cirrhosis.
Iredale et al (7) examined collagen-I mRNA expression for 3 days in bile duct-ligated rats. Collagen-I mRNA was not detected until 3 days after BDL, at which point a high level of expression was observed compared to the control. Our results indicate that collagen-I mRNA significantly increased with time from day 10 to day 42 following BDL, as compared to the control. Taken together, these data indicate that collagen-I mRNA expression is higher in the BDL liver than in the control liver for at least 3 days after BDL, and that hepatic fibrosis progresses with increasing collagen-I gene expression until day 42.
Napoli et al (8) examined the mRNA expression of TGF-ß1 in bile duct-ligated rats from day 2 to day 21, and observed a statistically significant increase in TGF-ß1 on days 14 and 21. Makino et al (10) , using a biliary obstruction (BO) rat model, also reported that TGF-ß1 mRNA increased significantly on days 14 and 21 after BO. Our results, which show that mRNA levels of TGF-ß1 were increased as of day 10 and sustained until day 42, are in agreement with these previous findings, while hepatic TGF-ß1 protein contents were significantly increased in a time-dependent manner. CTGF, a potent fibrogenic cytokines, is secreted by HCSs and is a downstream mediator of TGF-ß1. It was previously reported that, under normal conditions, the basal expression of CTGF is low, but that it becomes highly up-regulated during wound healing or fibrogenesis (14) . CTGF was reported to be a candidate marker of ongoing fibrogenesis in human chronic liver disease (15). Sedlaczek et al (14) reported that CTGF was up-regulated in close relation to TGF-ß1 in a cholestatic rat model. Paradis et al (16) also reported that CTGF was strongly expressed along the septa, with a significant increase around areas of ductular proliferation in bile duct-ligated rats. Our study demonstrated that CTGF mRNA was up-regulated from days 21 to 42 along with TGF-ß1 mRNA. Taken together, the results suggest that TGF-ß1 and CTGF are involved in cholestasis-induced hepatic fibrosis.
Progressive liver fibrosis results from reduced matrix degradation, that is, a reduction in MMPs and/or an increase in TIMPs in addition to an increase in ECM products. Iredale et al (7) showed that TIMP-1 mRNA expression was increased at 6 h, 24 h and 3 days following BDL. Furthermore, interstitial collagenase mRNA expression did not change until 3 days after BDL. The authors concluded that increased expression of TIMP-1 relative to interstitial collagenase would promote the progression of early-stage liver fibrosis. Kossakowska et al (9) demonstrated that MMP-2 activity was increased as of day 2 and continued to increase steadily until day 10 following BDL, although they could not detect MMP-2 mRNA expression with Northern hybridization. Our data reveal that MMP-2 mRNA expression was maintained at normal levels until day 21, and tended to be reduced by day 42. Although the reason for this discrepancy is unclear, mRNA expression of MMP-2 may be inconsistent with MMP-2 activation. However, MMP-2 mRNA expression is reported to be lower in cirrhotic human livers than in normal livers (17) , in agreement with our finding of liver cirrhosis on day 42 of this study. We also evaluated the sequential change in MMP-13 mRNA expression. MMP-13 mRNA expression was significantly up-regulated in bile duct-ligated rats from day 10 compared to the control rats. These higher values were maintained and were likely to be reduced at subsequent time points. The beneficial effect of collagenase during the resolution of hepatic fibrosis has been well documented in previous studies (18, 19) . Uchinami et al (20) reported that expression of MMP-13 mRNA increased significantly in the BDL livers of mice until 3 weeks, and that MMP-13 accelerated fibrogenesis in BDL livers by mediating the initial inflammation. In addition, various cytokines including IL-1 and TGF-ß1 stimulate MMP-13 production in HSCs (21,22) . The ECM serves as a binding reservoir for several cytokines, and MMPs release soluble cytokines through ECM degeneration (23) (24) (25) . These interactions between MMPs and cytokines may be involved in the fibrogenesis of BDL livers.
Our study showed that TIMP-1 mRNA expression was significantly up-regulated from day 21 in bile duct-ligated rat livers compared to control rats. Kossakowska et al (9) reported that TIMP-1 mRNA appeared on day 2 following BDL in rats, increased until day 10, and remained stable thereafter. Similar findings have also recently been reported in other experimental fibrotic models, such as CCl 4 -induced and immune-induced models (26) . TIMP-1 regulates hepatic fibrogenesis through the inhibition of MMPs. Enhanced expression of TIMP-1 relative to MMPs has been reported to promote the progression of hepatic fibrosis in early bile duct-ligated rat livers (7). TIMP-1 seems to be closely involved in the progression of hepatic fibrosis following BDL.
In conclusion, enhanced gene expression of collagen-I, TGF-ß1, CTGF and TIMP-1 and decreased gene expression of MMP-13 and MMP-2 were noted on day 42 in BDL-induced liver fibrosis. Table III . DNA microarray analysis.
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